Data Supports Using EXPAREL Infiltration To Control Postsurgical Pain

Transversus abdominis planes are increasingly being used for postsurgical pain control, and new data supports using the EXPAREL device from Pacira Pharmaceuticals, according to Herald Online.

The EXPAREL is a bupivacaine liposome injectable suspension which is infiltrated via the TAP. The data will be presented at the annual American Society of Regional Anesthesia and Pain Medicine meeting in November.

Twenty-four patients were evaluated for the study after undergoing robotic prostatectomy with EXPAREL via TAP infiltration. On average, these patients required less than one oxycodone tablet per day from discharge to the 10-day visit. One hundred percent of subjects also reported being satisfied or extremely satisfied with the postsurgical pain control.

More Articles on Anesthesia:
5 Ways to Increase Anesthesia Cost-Effectiveness in ASCs
Dr. Gregory Opdahl Joins Tillamook County General Hospital
Terri Brandt-Corriea Named Director of Surgical, Anesthesia Services

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast